0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Serum Albumin Market Research Report 2026
Published Date: 2026-04-20
|
Report Code: QYRE-Auto-13S8713
Home | Market Reports | Health| Nursing
Global Human Serum Albumin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Serum Albumin Market Research Report 2026

Code: QYRE-Auto-13S8713
Report
2026-04-20
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Serum Albumin Market Size

The global Human Serum Albumin market was valued at US$ 6728 million in 2025 and is anticipated to reach US$ 10390 million by 2032, at a CAGR of 6.5% from 2026 to 2032.

Human Serum Albumin Market

Human Serum Albumin Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human Serum Albumin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Human Serum Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The human serum albumin (HSA) market is driven by the increasing prevalence of liver diseases, nephrotic syndrome, and hypoalbuminemia, which require albumin-based therapies. Additionally, HSA is widely used in critical care settings for treating burns, shock, and surgical recovery, boosting its demand. The expanding applications of albumin in biopharmaceuticals, including drug delivery, vaccine formulation, and regenerative medicine, further fuel market growth. Rising healthcare expenditures, improvements in plasma collection infrastructure, and growing demand in emerging markets like China and India contribute to the industry's expansion.
However, the market faces challenges such as limited plasma supply and high production costs, as HSA is primarily derived from human plasma, which is subject to stringent donation regulations. Stringent government policies and safety concerns regarding pathogen transmission also hinder market growth. Additionally, competition from synthetic and recombinant HSA (rHSA) is increasing, though high production costs and market acceptance remain barriers. Overcoming supply chain constraints and advancing rHSA technologies will be crucial for sustaining growth in the global HSA market.
The key global producers of human serum albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrio, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%.
This report delivers a comprehensive overview of the global Human Serum Albumin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Serum Albumin. The Human Serum Albumin market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Serum Albumin market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Serum Albumin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Human Serum Albumin Market Report

Report Metric Details
Report Name Human Serum Albumin Market
Accounted market size in 2025 US$ 6728 million
Forecasted market size in 2032 US$ 10390 million
CAGR 6.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 20-25% Concentrations
  • 5% Concentrations
by Application
  • Therapeutics
  • Excipient
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Weiguang Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Human Serum Albumin manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Human Serum Albumin sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Human Serum Albumin Market growing?

Ans: The Human Serum Albumin Market witnessing a CAGR of 6.5% during the forecast period 2026-2032.

What is the Human Serum Albumin Market size in 2032?

Ans: The Human Serum Albumin Market size in 2032 will be US$ 10390 million.

What is the market share of major companies in Human Serum Albumin Market?

Ans: The key global producers of human serum albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrio, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share.

What is the CSL share in Human Serum Albumin Market?

Ans: The largest producer is CSL with a market share of 21.25%.

Who are the main players in the Human Serum Albumin Market report?

Ans: The main players in the Human Serum Albumin Market are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Weiguang Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang

What are the Application segmentation covered in the Human Serum Albumin Market report?

Ans: The Applications covered in the Human Serum Albumin Market report are Therapeutics, Excipient, Other

What are the Type segmentation covered in the Human Serum Albumin Market report?

Ans: The Types covered in the Human Serum Albumin Market report are 20-25% Concentrations, 5% Concentrations

1 Human Serum Albumin Market Overview
1.1 Product Definition
1.2 Human Serum Albumin by Type
1.2.1 Global Human Serum Albumin Market Value by Type: 2025 vs 2032
1.2.2 20-25% Concentrations
1.2.3 5% Concentrations
1.3 Human Serum Albumin by Application
1.3.1 Global Human Serum Albumin Market Value by Application: 2025 vs 2032
1.3.2 Therapeutics
1.3.3 Excipient
1.3.4 Other
1.4 Global Human Serum Albumin Market Size Estimates and Forecasts
1.4.1 Global Human Serum Albumin Revenue 2021–2032
1.4.2 Global Human Serum Albumin Sales 2021–2032
1.4.3 Global Human Serum Albumin Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Human Serum Albumin Market Competition by Manufacturers
2.1 Global Human Serum Albumin Sales Market Share by Manufacturers (2021–2026)
2.2 Global Human Serum Albumin Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Human Serum Albumin Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Human Serum Albumin, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Human Serum Albumin, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Human Serum Albumin, Product Types and Applications
2.7 Global Key Manufacturers of Human Serum Albumin, Date of Entry into the Industry
2.8 Global Human Serum Albumin Market Competitive Situation and Trends
2.8.1 Global Human Serum Albumin Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Human Serum Albumin Players Market Share by Revenue
2.8.3 Global Human Serum Albumin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Serum Albumin Market Scenario by Region
3.1 Global Human Serum Albumin Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Human Serum Albumin Sales by Region: 2021–2032
3.2.1 Global Human Serum Albumin Sales by Region: 2021–2026
3.2.2 Global Human Serum Albumin Sales by Region: 2027–2032
3.3 Global Human Serum Albumin Revenue by Region: 2021–2032
3.3.1 Global Human Serum Albumin Revenue by Region: 2021–2026
3.3.2 Global Human Serum Albumin Revenue by Region: 2027–2032
3.4 North America Human Serum Albumin Market Facts & Figures by Country
3.4.1 North America Human Serum Albumin Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Human Serum Albumin Sales by Country (2021–2032)
3.4.3 North America Human Serum Albumin Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Serum Albumin Market Facts & Figures by Country
3.5.1 Europe Human Serum Albumin Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Human Serum Albumin Sales by Country (2021–2032)
3.5.3 Europe Human Serum Albumin Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Serum Albumin Market Facts & Figures by Region
3.6.1 Asia Pacific Human Serum Albumin Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Human Serum Albumin Sales by Region (2021–2032)
3.6.3 Asia Pacific Human Serum Albumin Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Serum Albumin Market Facts & Figures by Country
3.7.1 Latin America Human Serum Albumin Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Human Serum Albumin Sales by Country (2021–2032)
3.7.3 Latin America Human Serum Albumin Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Serum Albumin Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Serum Albumin Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Human Serum Albumin Sales by Country (2021–2032)
3.8.3 Middle East and Africa Human Serum Albumin Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Serum Albumin Sales by Type (2021–2032)
4.1.1 Global Human Serum Albumin Sales by Type (2021–2026)
4.1.2 Global Human Serum Albumin Sales by Type (2027–2032)
4.1.3 Global Human Serum Albumin Sales Market Share by Type (2021–2032)
4.2 Global Human Serum Albumin Revenue by Type (2021–2032)
4.2.1 Global Human Serum Albumin Revenue by Type (2021–2026)
4.2.2 Global Human Serum Albumin Revenue by Type (2027–2032)
4.2.3 Global Human Serum Albumin Revenue Market Share by Type (2021–2032)
4.3 Global Human Serum Albumin Price by Type (2021–2032)
5 Segment by Application
5.1 Global Human Serum Albumin Sales by Application (2021–2032)
5.1.1 Global Human Serum Albumin Sales by Application (2021–2026)
5.1.2 Global Human Serum Albumin Sales by Application (2027–2032)
5.1.3 Global Human Serum Albumin Sales Market Share by Application (2021–2032)
5.2 Global Human Serum Albumin Revenue by Application (2021–2032)
5.2.1 Global Human Serum Albumin Revenue by Application (2021–2026)
5.2.2 Global Human Serum Albumin Revenue by Application (2027–2032)
5.2.3 Global Human Serum Albumin Revenue Market Share by Application (2021–2032)
5.3 Global Human Serum Albumin Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Grifols
6.1.1 Grifols Company Information
6.1.2 Grifols Description and Business Overview
6.1.3 Grifols Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Grifols Human Serum Albumin Product Portfolio
6.1.5 Grifols Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 CSL Human Serum Albumin Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Company Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Takeda Human Serum Albumin Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Octapharma Human Serum Albumin Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 CBPO
6.5.1 CBPO Company Information
6.5.2 CBPO Description and Business Overview
6.5.3 CBPO Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 CBPO Human Serum Albumin Product Portfolio
6.5.5 CBPO Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Company Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hualan Bio Human Serum Albumin Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Kedrion
6.7.1 Kedrion Company Information
6.7.2 Kedrion Description and Business Overview
6.7.3 Kedrion Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Kedrion Human Serum Albumin Product Portfolio
6.7.5 Kedrion Recent Developments/Updates
6.8 Shanghai RAAS
6.8.1 Shanghai RAAS Company Information
6.8.2 Shanghai RAAS Description and Business Overview
6.8.3 Shanghai RAAS Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Shanghai RAAS Human Serum Albumin Product Portfolio
6.8.5 Shanghai RAAS Recent Developments/Updates
6.9 LFB Group
6.9.1 LFB Group Company Information
6.9.2 LFB Group Description and Business Overview
6.9.3 LFB Group Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 LFB Group Human Serum Albumin Product Portfolio
6.9.5 LFB Group Recent Developments/Updates
6.10 Weiguang Bio
6.10.1 Weiguang Bio Company Information
6.10.2 Weiguang Bio Description and Business Overview
6.10.3 Weiguang Bio Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Weiguang Bio Human Serum Albumin Product Portfolio
6.10.5 Weiguang Bio Recent Developments/Updates
6.11 Tiantan Bio
6.11.1 Tiantan Bio Company Information
6.11.2 Tiantan Bio Description and Business Overview
6.11.3 Tiantan Bio Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Tiantan Bio Human Serum Albumin Product Portfolio
6.11.5 Tiantan Bio Recent Developments/Updates
6.12 Shuanglin Bio
6.12.1 Shuanglin Bio Company Information
6.12.2 Shuanglin Bio Description and Business Overview
6.12.3 Shuanglin Bio Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Shuanglin Bio Human Serum Albumin Product Portfolio
6.12.5 Shuanglin Bio Recent Developments/Updates
6.13 Boya Bio
6.13.1 Boya Bio Company Information
6.13.2 Boya Bio Description and Business Overview
6.13.3 Boya Bio Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Boya Bio Human Serum Albumin Product Portfolio
6.13.5 Boya Bio Recent Developments/Updates
6.14 Yuanda Shuyang
6.14.1 Yuanda Shuyang Company Information
6.14.2 Yuanda Shuyang Description and Business Overview
6.14.3 Yuanda Shuyang Human Serum Albumin Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Yuanda Shuyang Human Serum Albumin Product Portfolio
6.14.5 Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Serum Albumin Industry Chain Analysis
7.2 Human Serum Albumin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Serum Albumin Production Mode & Process Analysis
7.4 Human Serum Albumin Sales and Marketing
7.4.1 Human Serum Albumin Sales Channels
7.4.2 Human Serum Albumin Distributors
7.5 Human Serum Albumin Customer Analysis
8 Human Serum Albumin Market Dynamics
8.1 Human Serum Albumin Industry Trends
8.2 Human Serum Albumin Market Drivers
8.3 Human Serum Albumin Market Challenges
8.4 Human Serum Albumin Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Human Serum Albumin Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Human Serum Albumin Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Human Serum Albumin Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Human Serum Albumin Sales (MT) of Key Manufacturers (2021–2026)
 Table 5. Global Human Serum Albumin Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Human Serum Albumin Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Human Serum Albumin Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Human Serum Albumin Average Price (US$/Kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Human Serum Albumin, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Human Serum Albumin, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Human Serum Albumin, Product Types and Applications
 Table 12. Global Key Manufacturers of Human Serum Albumin, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Serum Albumin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Human Serum Albumin Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Serum Albumin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Human Serum Albumin Sales by Region (MT), 2021–2026
 Table 18. Global Human Serum Albumin Sales Market Share by Region (2021–2026)
 Table 19. Global Human Serum Albumin Sales by Region (MT), 2027–2032
 Table 20. Global Human Serum Albumin Sales Market Share by Region (2027–2032)
 Table 21. Global Human Serum Albumin Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Human Serum Albumin Revenue Market Share by Region (2021–2026)
 Table 23. Global Human Serum Albumin Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Human Serum Albumin Revenue Market Share by Region (2027–2032)
 Table 25. North America Human Serum Albumin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Human Serum Albumin Sales by Country (MT), 2021–2026
 Table 27. North America Human Serum Albumin Sales by Country (MT), 2027–2032
 Table 28. North America Human Serum Albumin Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Human Serum Albumin Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Human Serum Albumin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Human Serum Albumin Sales by Country (MT), 2021–2026
 Table 32. Europe Human Serum Albumin Sales by Country (MT), 2027–2032
 Table 33. Europe Human Serum Albumin Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Human Serum Albumin Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Human Serum Albumin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Human Serum Albumin Sales by Region (MT), 2021–2026
 Table 37. Asia Pacific Human Serum Albumin Sales by Region (MT), 2027–2032
 Table 38. Asia Pacific Human Serum Albumin Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Human Serum Albumin Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Human Serum Albumin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Human Serum Albumin Sales by Country (MT), 2021–2026
 Table 42. Latin America Human Serum Albumin Sales by Country (MT), 2027–2032
 Table 43. Latin America Human Serum Albumin Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Human Serum Albumin Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Human Serum Albumin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Human Serum Albumin Sales by Country (MT), 2021–2026
 Table 47. Middle East and Africa Human Serum Albumin Sales by Country (MT), 2027–2032
 Table 48. Middle East and Africa Human Serum Albumin Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Human Serum Albumin Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Human Serum Albumin Sales (MT) by Type (2021–2026)
 Table 51. Global Human Serum Albumin Sales (MT) by Type (2027–2032)
 Table 52. Global Human Serum Albumin Sales Market Share by Type (2021–2026)
 Table 53. Global Human Serum Albumin Sales Market Share by Type (2027–2032)
 Table 54. Global Human Serum Albumin Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Human Serum Albumin Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Human Serum Albumin Revenue Market Share by Type (2021–2026)
 Table 57. Global Human Serum Albumin Revenue Market Share by Type (2027–2032)
 Table 58. Global Human Serum Albumin Price (US$/Kg) by Type (2021–2026)
 Table 59. Global Human Serum Albumin Price (US$/Kg) by Type (2027–2032)
 Table 60. Global Human Serum Albumin Sales (MT) by Application (2021–2026)
 Table 61. Global Human Serum Albumin Sales (MT) by Application (2027–2032)
 Table 62. Global Human Serum Albumin Sales Market Share by Application (2021–2026)
 Table 63. Global Human Serum Albumin Sales Market Share by Application (2027–2032)
 Table 64. Global Human Serum Albumin Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Human Serum Albumin Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Human Serum Albumin Revenue Market Share by Application (2021–2026)
 Table 67. Global Human Serum Albumin Revenue Market Share by Application (2027–2032)
 Table 68. Global Human Serum Albumin Price (US$/Kg) by Application (2021–2026)
 Table 69. Global Human Serum Albumin Price (US$/Kg) by Application (2027–2032)
 Table 70. Grifols Company Information
 Table 71. Grifols Description and Business Overview
 Table 72. Grifols Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 73. Grifols Human Serum Albumin Product
 Table 74. Grifols Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 78. CSL Human Serum Albumin Product
 Table 79. CSL Recent Developments/Updates
 Table 80. Takeda Company Information
 Table 81. Takeda Description and Business Overview
 Table 82. Takeda Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 83. Takeda Human Serum Albumin Product
 Table 84. Takeda Recent Developments/Updates
 Table 85. Octapharma Company Information
 Table 86. Octapharma Description and Business Overview
 Table 87. Octapharma Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 88. Octapharma Human Serum Albumin Product
 Table 89. Octapharma Recent Developments/Updates
 Table 90. CBPO Company Information
 Table 91. CBPO Description and Business Overview
 Table 92. CBPO Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 93. CBPO Human Serum Albumin Product
 Table 94. CBPO Recent Developments/Updates
 Table 95. Hualan Bio Company Information
 Table 96. Hualan Bio Description and Business Overview
 Table 97. Hualan Bio Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 98. Hualan Bio Human Serum Albumin Product
 Table 99. Hualan Bio Recent Developments/Updates
 Table 100. Kedrion Company Information
 Table 101. Kedrion Description and Business Overview
 Table 102. Kedrion Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 103. Kedrion Human Serum Albumin Product
 Table 104. Kedrion Recent Developments/Updates
 Table 105. Shanghai RAAS Company Information
 Table 106. Shanghai RAAS Description and Business Overview
 Table 107. Shanghai RAAS Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 108. Shanghai RAAS Human Serum Albumin Product
 Table 109. Shanghai RAAS Recent Developments/Updates
 Table 110. LFB Group Company Information
 Table 111. LFB Group Description and Business Overview
 Table 112. LFB Group Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 113. LFB Group Human Serum Albumin Product
 Table 114. LFB Group Recent Developments/Updates
 Table 115. Weiguang Bio Company Information
 Table 116. Weiguang Bio Description and Business Overview
 Table 117. Weiguang Bio Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 118. Weiguang Bio Human Serum Albumin Product
 Table 119. Weiguang Bio Recent Developments/Updates
 Table 120. Tiantan Bio Company Information
 Table 121. Tiantan Bio Description and Business Overview
 Table 122. Tiantan Bio Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 123. Tiantan Bio Human Serum Albumin Product
 Table 124. Tiantan Bio Recent Developments/Updates
 Table 125. Shuanglin Bio Company Information
 Table 126. Shuanglin Bio Description and Business Overview
 Table 127. Shuanglin Bio Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 128. Shuanglin Bio Human Serum Albumin Product
 Table 129. Shuanglin Bio Recent Developments/Updates
 Table 130. Boya Bio Company Information
 Table 131. Boya Bio Description and Business Overview
 Table 132. Boya Bio Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 133. Boya Bio Human Serum Albumin Product
 Table 134. Boya Bio Recent Developments/Updates
 Table 135. Yuanda Shuyang Company Information
 Table 136. Yuanda Shuyang Description and Business Overview
 Table 137. Yuanda Shuyang Human Serum Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 138. Yuanda Shuyang Human Serum Albumin Product
 Table 139. Yuanda Shuyang Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Human Serum Albumin Distributors List
 Table 143. Human Serum Albumin Customers List
 Table 144. Human Serum Albumin Market Trends
 Table 145. Human Serum Albumin Market Drivers
 Table 146. Human Serum Albumin Market Challenges
 Table 147. Human Serum Albumin Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Serum Albumin
 Figure 2. Global Human Serum Albumin Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Human Serum Albumin Market Share by Type: 2025 & 2032
 Figure 4. 20-25% Concentrations Product Picture
 Figure 5. 5% Concentrations Product Picture
 Figure 6. Global Human Serum Albumin Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Human Serum Albumin Market Share by Application: 2025 & 2032
 Figure 8. Therapeutics
 Figure 9. Excipient
 Figure 10. Other
 Figure 11. Global Human Serum Albumin Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Human Serum Albumin Market Size (US$ Million), 2021–2032
 Figure 13. Global Human Serum Albumin Sales (MT), 2021–2032
 Figure 14. Global Human Serum Albumin Average Price (US$/Kg), 2021–2032
 Figure 15. Human Serum Albumin Report Years Considered
 Figure 16. Human Serum Albumin Sales Share by Manufacturers in 2025
 Figure 17. Global Human Serum Albumin Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Human Serum Albumin Players: Market Share by Revenue in Human Serum Albumin in 2025
 Figure 19. Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Human Serum Albumin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Human Serum Albumin Sales Market Share by Country (2021–2032)
 Figure 22. North America Human Serum Albumin Revenue Market Share by Country (2021–2032)
 Figure 23. United States Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Human Serum Albumin Sales Market Share by Country (2021–2032)
 Figure 26. Europe Human Serum Albumin Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Human Serum Albumin Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Human Serum Albumin Revenue Market Share by Region (2021–2032)
 Figure 34. China Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Human Serum Albumin Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Human Serum Albumin Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Human Serum Albumin Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Human Serum Albumin Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Human Serum Albumin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Human Serum Albumin by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Human Serum Albumin by Type (2021–2032)
 Figure 53. Global Human Serum Albumin Price (US$/Kg) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Human Serum Albumin by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Human Serum Albumin by Application (2021–2032)
 Figure 56. Global Human Serum Albumin Price (US$/Kg) by Application (2021–2032)
 Figure 57. Human Serum Albumin Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools